DRUG COMPANIES FACE NEW STUDY; But Dirksen Delays Start of Kefauver Inquiry Into Latin Price Pressure 91 Per Cent Price Cut DRUG COMPANIES FACE NEW STUDY Dirksen Objects Kefauver Opposed Move
Sen Kefauver repts same big US drug cos act illegally to squelch program in which US cos and Latin-Amer Govts sell prescription drugs in Latin Amer under generic names with resulting big price cuts; his subcom subpoenaes documents from cos (unidentified), Pharmaceutical Mfrs Assn and execs Dr A Smith and W Wien; charges cos apparently tried to have US State Dept bar US participation and discourage program; meets, at Sen Dirksen request, with Sen Foreign Relations Com and State Dept repr